Clinical Trial Update: A Clinical Trial of Adjunctive and Monotherapy PRAX-114 in Participants With Major Depressive Disorder [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for PRAX-114 as adjunctive and monotherapy in major depressive disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• PRAX-114 (PRAX-114)

Snippet

Sponsor: Praxis Precision Medicines | Conditions: Major Depressive Disorder | Phase 2 | Status: COMPLETED